ACNOCIN
Live / Applied — First extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 12 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98693653
- Mark type
- Stylized text
- Filed
- 12 Aug 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Xavier L. Suarez
Goods and services
- Class 005 — Pharmaceuticals: Skin treatment pharmaceutical preparations, namely, powders, gels and liquids for wound care.
Owner
- Stratus Pharmaceuticals, Inc., Miami, FL, US
- Stratus Pharmaceuticals, Inc., Miami, FL, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 1 GRANTED
- 02 Jan 2026 — SOU EXTENSION 1 FILED
- 04 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 02 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 02 Feb 2026 — PETITION TO REVIVE-GRANTED
- 02 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER